Listen to The Point Being, a podcast from the Ipsos Polling Team, where Chris Jackson and Phil Elwood discuss this week’s numbers.
In the wake of the Las Vegas mass shooting, public concern about terrorism has ticked up slightly, by two points (now at 14%, up from 12% last week). However, healthcare (19%) remains the most important problem facing the US today. Although Republicans in Congress are currently working on tax reform, only 10% of Americans prioritize the economy.
President Trump’s approval is at 37% this week, one point lower than last week (38%). Among Democrats, his approval fell 4 points to 9% this week, while Republican approval grew to 78% from 76%. Overall, 43% of Americans still strongly disapprove of the president, outweighing all of those who approve of him (37%).
In our latest approval by state map, Trump’s approval has stayed mostly consistent across America. Although still relatively popular in the Northwest, he has experienced drops in many states including Montana, Idaho, Wyoming and Utah. In the six-month roll up of approval, his approval has not risen in any state.
In our latest Wh-Exit poll where Americans predict the next White House or Executive Branch official to be terminated or resign, Jeff Sessions again tops the list (15%). After dodging tweets from the president over the weekend, Rex Tillerson only went up 1 percentage point, now at 8% and tied with Steve Mnuchin.
These are findings from an Ipsos poll conducted for Thomson Reuters September 29 - October 3, 2017. For the survey, a sample of 1,659 Americans, ages 18+ were interviewed online.
[WEBINAR] Messaging & Motivation: Engaging Participants in Healthcare Research
August 27 - One of the biggest challenges researchers face is recruiting and retaining participants, especially for longitudinal studies or intense clinical trials. Join us for a complimentary webinar to learn innovative ways to enhance recruitment, and maintain participant engagement.
[EVENT] International Conference on Pharmacoepidemiology & Therapeutic Risk Management
August 22-26, Ipsos Healthcare’s Global Evidence, Value and Access (GEVA) team will be exhibiting at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) being held in Prague, CZ.